Cite
HARVARD Citation
Yang, K. et al. (2018). KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK–ERK pathway in pancreatic cancer. International journal of cancer. 142 (11), pp. 2323-2334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yang, K. et al. (2018). KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK–ERK pathway in pancreatic cancer. International journal of cancer. 142 (11), pp. 2323-2334. [Online].